• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Granulocyte Transfusions Decrease the Risk of Infections in Neutropenia Patients

July 10, 2015

Scanning electron micrograph of a human neutrophil ingesting MRSA.

Granulocyte transfusions have been increasingly given to hematology-oncology patients with disease-related or therapy-related neutropenia to prevent and treat bacterial and fungal infections.  An updated Cochrane review of all published randomized controlled trials (11 trials with 653 patients) compared the incidence of mortality and infections in neutropenic patients who received prophylactic granulocyte transfusions compared to patients who did not.  Although prophylactic granulocyte transfusions did not affect the risk of mortality, prophylactic granulocyte transfusions decreased the risk of bacterial and fungal infections, especially for patients who receive larger doses of at least 1.0 X 1010 granulocytes per day.  However, the quality of evidence is low and the risk of serious adverse events could not be assessed because adverse events were not reported for all patients.  Additional trials are needed to fully evaluate the efficacy of prophylactic granulocyte transfusions.

 

Reference

1. Estcourt LJ, Stanworth S, Doree C, Blanco P, Hopewell S, Trivella M, Massey E. Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev 2015;6: CD005341.

Filed Under

  • News
  • Special Transfusion Situations

Recommended

  • New PLASMIC Scoring System to Help Diagnose Thrombotic Thrombocytopenic Purpura

  • RBC and Plasma Transfusions Continue to Decline among US Hospitalizations

  • mRNA-1273 Vaccine Safe and Induces anti-SARS-CoV-2 Immune Responses

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley